BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12839582)

  • 1. cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.
    Usener D; Schadendorf D; Koch J; Dübel S; Eichmüller S
    J Invest Dermatol; 2003 Jul; 121(1):198-206. PubMed ID: 12839582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity.
    Eichmüller S; Usener D; Thiel D; Schadendorf D
    Int J Cancer; 2003 Apr; 104(4):482-7. PubMed ID: 12584747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological detection of cutaneous T-cell lymphoma-associated antigens.
    Eichmuller S; Usener D; Dummer R; Stein A; Thiel D; Schadendorf D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):629-34. PubMed ID: 11149944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer.
    Gerhardt A; Usener D; Keese M; Sturm J; Schadendorf D; Eichmüller S
    Cancer Lett; 2004 May; 208(2):197-206. PubMed ID: 15142679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
    Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
    Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selectively expressed genes and antigens in CTCL.
    Hartmann TB; Mattern E; Wiedemann N; van Doorn R; Willemze R; Niikura T; Hildenbrand R; Schadendorf D; Eichmüller SB
    Exp Dermatol; 2008 Apr; 17(4):324-34. PubMed ID: 17979976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
    van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary origin and human-specific expansion of a cancer/testis antigen gene family.
    Zhang Q; Su B
    Mol Biol Evol; 2014 Sep; 31(9):2365-75. PubMed ID: 24916032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the testis-specific protein 10 (TSGA10) as serologically defined tumour-associated antigen in primary cutaneous T-cell lymphoma.
    Theinert SM; Pronest MM; Peris K; Sterry W; Walden P
    Br J Dermatol; 2005 Sep; 153(3):639-41. PubMed ID: 16120156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma.
    Hartmann TB; Thiel D; Dummer R; Schadendorf D; Eichmüller S
    Br J Dermatol; 2004 Feb; 150(2):252-8. PubMed ID: 14996095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line.
    Zhou Y; Toth M; Hamman MS; Monahan SJ; Lodge PA; Boynton AL; Salgaller ML
    Biochem Biophys Res Commun; 2002 Jan; 290(2):830-8. PubMed ID: 11785977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
    Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N
    Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTp11, a novel member of the family of human cancer/testis antigens.
    Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
    Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and expression analysis of feline melanoma antigen (MAGE) obtained from a lymphoma cell line.
    Ma Z; Khatlani TS; Li L; Sasaki K; Okuda M; Inokuma H; Onishi T
    Vet Immunol Immunopathol; 2001 Dec; 83(3-4):241-52. PubMed ID: 11730932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Fitzgerald EB; Kawakami Y; Rosenberg SA
    J Immunol; 1997 Jul; 159(1):303-8. PubMed ID: 9200467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
    Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
    Vaughan HA; St Clair F; Scanlan MJ; Chen YT; Maraskovsky E; Sizeland A; Old LJ; Cebon J
    Cancer Immun; 2004 Jul; 4():5. PubMed ID: 15255672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.